BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 26130187)

  • 1. Current and Emerging Therapeutic Strategies for the Treatment of Meibomian Gland Dysfunction (MGD).
    Thode AR; Latkany RA
    Drugs; 2015 Jul; 75(11):1177-85. PubMed ID: 26130187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanical meibomian gland squeezing combined with eyelid scrubs and warm compresses for the treatment of meibomian gland dysfunction.
    Lee H; Kim M; Park SY; Kim EK; Seo KY; Kim TI
    Clin Exp Optom; 2017 Nov; 100(6):598-602. PubMed ID: 28295626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of an automated thermodynamic treatment (LipiFlow®) system for meibomian gland dysfunction: a prospective, randomized, observer-masked trial.
    Finis D; Hayajneh J; König C; Borrelli M; Schrader S; Geerling G
    Ocul Surf; 2014 Apr; 12(2):146-54. PubMed ID: 24725326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of using a combination of lid wipes, eye drops, and omega-3 supplements on meibomian gland functionality in patients with lipid deficient/evaporative dry eye.
    Korb DR; Blackie CA; Finnemore VM; Douglass T
    Cornea; 2015 Apr; 34(4):407-12. PubMed ID: 25651491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of topical loteprednol etabonate with lid hygiene on tear cytokines and meibomian gland dysfunction in prosthetic eye wearers.
    Ko JS; Seo Y; Chae MK; Jang SY; Yoon JS
    Eye (Lond); 2018 Feb; 32(2):439-445. PubMed ID: 29052604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Eyelid Hygiene Detergent on Obstructive Meibomian Gland Dysfunction.
    Tanabe H; Kaido M; Kawashima M; Ishida R; Ayaki M; Tsubota K
    J Oleo Sci; 2019 Jan; 68(1):67-78. PubMed ID: 30542004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of topical loteprednol etabonate on tear cytokines and clinical outcomes in moderate and severe meibomian gland dysfunction: randomized clinical trial.
    Lee H; Chung B; Kim KS; Seo KY; Choi BJ; Kim TI
    Am J Ophthalmol; 2014 Dec; 158(6):1172-1183.e1. PubMed ID: 25128594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical azithromycin and oral doxycycline therapy of meibomian gland dysfunction: a comparative clinical and spectroscopic pilot study.
    Foulks GN; Borchman D; Yappert M; Kakar S
    Cornea; 2013 Jan; 32(1):44-53. PubMed ID: 22668581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-masked study to evaluate the effect of omega-3 fatty acids supplementation in meibomian gland dysfunction.
    Oleñik A; Jiménez-Alfaro I; Alejandre-Alba N; Mahillo-Fernández I
    Clin Interv Aging; 2013; 8():1133-8. PubMed ID: 24039409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of efficacy of topical azithromycin 1.5 per cent ophthalmic solution for the treatment of meibomian gland dysfunction.
    Balci O; Gulkilik G
    Clin Exp Optom; 2018 Jan; 101(1):18-22. PubMed ID: 28677153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single LipiFlow® Thermal Pulsation System treatment improves meibomian gland function and reduces dry eye symptoms for 9 months.
    Greiner JV
    Curr Eye Res; 2012 Apr; 37(4):272-8. PubMed ID: 22324772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction.
    Baudouin C; Messmer EM; Aragona P; Geerling G; Akova YA; Benítez-del-Castillo J; Boboridis KG; Merayo-Lloves J; Rolando M; Labetoulle M
    Br J Ophthalmol; 2016 Mar; 100(3):300-6. PubMed ID: 26781133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging treatment options for meibomian gland dysfunction.
    Qiao J; Yan X
    Clin Ophthalmol; 2013; 7():1797-803. PubMed ID: 24043929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meibomian Gland Disease: The Role of Gland Dysfunction in Dry Eye Disease.
    Chhadva P; Goldhardt R; Galor A
    Ophthalmology; 2017 Nov; 124(11S):S20-S26. PubMed ID: 29055358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Tear Fluid Production as a Compensatory Response to Meibomian Gland Loss: A Multicenter Cross-sectional Study.
    Arita R; Morishige N; Koh S; Shirakawa R; Kawashima M; Sakimoto T; Suzuki T; Tsubota K
    Ophthalmology; 2015 May; 122(5):925-33. PubMed ID: 25626757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral linoleic and gamma-linolenic acid on meibomian gland dysfunction.
    Pinna A; Piccinini P; Carta F
    Cornea; 2007 Apr; 26(3):260-4. PubMed ID: 17413949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of an eyelid warming device (Blephasteam) for the management of ocular surface diseases in France: the ESPOIR study.
    Doan S; Chiambaretta F; Baudouin C;
    J Fr Ophtalmol; 2014 Dec; 37(10):763-72. PubMed ID: 25282620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversibility of Gland Dropout and Significance of Eyelid Hygiene Treatment in Meibomian Gland Dysfunction.
    Yin Y; Gong L
    Cornea; 2017 Mar; 36(3):332-337. PubMed ID: 27755193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meibomian Gland Dysfunction: Recent Progress Worldwide and in Japan.
    Amano S
    Invest Ophthalmol Vis Sci; 2018 Nov; 59(14):DES87-DES93. PubMed ID: 30481811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eyelid cleansing with ointment for obstructive meibomian gland dysfunction.
    Kaido M; Ibrahim OM; Kawashima M; Ishida R; Sato EA; Tsubota K
    Jpn J Ophthalmol; 2017 Jan; 61(1):124-130. PubMed ID: 27699522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.